Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02424617
Title A Study of BGB324 in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BerGenBio AS
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Moores UC San Diego Cancer Center San Diego California 92093-0698 United States Details
Moffit Cancer Centre Tampa Florida 33612 United States Details
Horizon Oncology,1345 Unity Place Lafayette Indiana 47905 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Research Unit Dallas Texas 75230 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390-9105 United States Details
Oncology Consultants Houston Texas 77030 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field